CAS 2178049-58-4

Formel: C27H28F2N6O3

InChl: InChI=1S/C27H28F2N6O3/c28-17-4-5-18(20(29)12-17)23-13-22(34-38-23)25(37)32-21-6-11-35(14-16-2-3-16)15-19(21)24(36)33-27(7-8-27)26-30-9-1-10-31-26/h1,4-5,9-10,12-13,16,19,21H,2-3,6-8,11,14-15H2,(H,32,37)(H,33,36)/t19-,21-/m0/s1

InChI Key: IIDSHAJKXPUYSL-FPOVZHCZSA-N

SMILES: C1CN(C[C@@H]([C@H]1NC(=O)C2=NOC(=C2)C3=C(C=C(C=C3)F)F)C(=O)NC4(CC4)C5=NC=CC=N5)CC6CC6

ACT-1004-1239

CAS: 2178049-58-4

ACT-1004-1239

Formel: C₂₇H₂₈F₂N₆O₃

Reinheit: ≥98%

Molekulargewicht: 522.55

Ref: 54-BUP21165

(3S,4S)-1-(Cyclopropylmethyl)-4-[[[5-(2,4-difluorophenyl)-3-isoxazolyl]carbonyl]amino]-N-[1-(2-pyrimidinyl)cyclopropyl]-3-piperidinecarboxamide

CAS: 2178049-58-4

Reinheit: 99%

Ref: IN-DA0248VO

ACT-1004-1239

CAS: 2178049-58-4

ACT-1004-1239 is a CXCR7 antagonist with immunomodulatory and myelination-promoting effects, used for research on inflammatory demyelinating diseases.

Formel: C₂₇H₂₈F₂N₆O₃

Reinheit: 98.31%

Farbe und Form: Solid

Molekulargewicht: 522.55

Ref: TM-T39665